Related by context. All words. (Click for frequent words.) 78 cytoreductive surgery 75 postoperative chemotherapy 74 curative resection 74 lymph node dissection 74 tumor resection 74 surgical debulking 73 hepatic metastases 73 preoperative chemotherapy 73 concurrent chemoradiation 73 liver resection 73 locoregional recurrence 73 renal tumors 73 pelvic lymphadenectomy 72 cystectomy 72 Adjuvant chemotherapy 72 lymphadenectomy 72 debulking surgery 72 neoadjuvant therapy 72 Surgical resection 72 underwent resection 72 chemoradiotherapy 72 adjuvant radiotherapy 72 pulmonary metastases 72 pneumonectomy 71 androgen ablation 71 Radical prostatectomy 71 radical nephrectomy 71 HIPEC 71 Mitomycin C 71 endoscopic resection 71 nephron sparing surgery 71 transplantation HCT 71 node dissection 71 peritoneal carcinomatosis 71 skeletal metastases 70 Radiofrequency ablation 70 intraperitoneal chemotherapy 70 chemoradiation 70 leiomyomas 70 radiochemotherapy 70 recurrent metastatic 70 resectable 70 R0 resection 70 cisplatin chemotherapy 70 chemoradiation therapy 70 operable breast cancer 70 intravesical therapy 70 surgical excision 70 radioiodine therapy 70 thoracoscopic lobectomy 70 locoregional 70 allogeneic HSCT 70 cervical lymph nodes 70 liver metastasis 70 clinically localized prostate 69 localized renal 69 external beam radiotherapy 69 precursor lesions 69 ALND 69 androgen deprivation 69 parathyroidectomy 69 Surgical excision 69 total thyroidectomy 69 epithelial tumors 69 autologous SCT 69 extrapleural pneumonectomy 69 subconjunctival injection 69 myeloablative 69 palliation 69 intra arterial chemotherapy 69 endometrial carcinoma 69 metastatic bladder 69 chemotherapeutic regimens 69 neoadjuvant chemotherapy 69 percutaneous drainage 69 adjuvant radiation 69 cytotoxic therapy 69 colorectal liver metastases 69 neoadjuvant 69 radiotherapy RT 69 pCR 69 NMIBC 69 recurrent glioblastoma multiforme 69 hepatorenal syndrome 69 pancreatic adenocarcinoma 69 spinal metastases 69 candidemia 69 reimplantation 69 chemoembolization 68 transarterial 68 transurethral resection 68 lung metastases 68 axillary dissection 68 endocrine therapies 68 hepatectomy 68 perioperative morbidity 68 invasive aspergillosis 68 complete cytogenetic response 68 salpingo oophorectomy 68 aromatase inhibitor therapy 68 orchiectomy 68 Liver transplantation 68 metastatic malignant 68 prostate carcinoma 68 androgen suppression 68 abdominal hysterectomy 68 postoperative radiotherapy 68 radical cystectomy 68 chronic GVHD 68 recurrent ovarian 68 adrenalectomy 68 ovarian carcinoma 68 biliary tract cancer 68 gastric adenocarcinoma 68 colorectal metastases 68 thymectomy 68 gastrectomy 68 biochemical relapse 68 intraperitoneal therapy 68 lung resection 68 leiomyoma 68 GISTs 68 graft occlusion 68 EBRT 68 pulmonary resection 68 nephrectomy 68 pyelonephritis 68 hepatic resection 68 intraductal 68 liver metastases 67 metastatic gastric 67 pulmonary artery banding 67 ABVD 67 nonmetastatic 67 locoregional disease 67 metastatic bone 67 esophagogastric 67 fallopian tube carcinoma 67 CR nPR 67 squamous cell carcinoma SCC 67 curative therapy 67 adjuvant tamoxifen 67 PSA nadir 67 underwent surgical resection 67 papillary renal cell carcinoma 67 colon resection 67 neoadjuvant treatment 67 metastatic lesions 67 Endometrial 67 enucleation 67 sentinel lymph node biopsy 67 castrate resistant 67 malignant ascites 67 partial nephrectomy 67 lenalidomide dexamethasone 67 colorectal cancer liver metastases 67 cervical lymph node 67 relapsed MM 67 urothelial carcinoma 67 laparoscopically assisted 67 oral clodronate 67 allogeneic hematopoietic stem cell 67 Doxil ® 67 autologous hematopoietic stem cell 67 metastatic malignant melanoma 67 nodal metastases 67 anti angiogenic agents 67 prostate carcinomas 67 adjuvant therapy 67 sarcomatoid 67 pT2 67 orchidectomy 67 tumor necrosis 67 renal cell carcinomas 67 malignant pleural mesothelioma 67 cytogenetic responses 67 radiation therapy SBRT 67 intestinal metaplasia 67 resections 67 CCyR 66 MALT lymphoma 66 retroperitoneal 66 thromboprophylaxis 66 grade cervical intraepithelial 66 systemic ALCL 66 postoperative morbidity 66 T1a 66 ablative therapy 66 Cystectomy 66 adjuvant therapies 66 breast carcinoma 66 tumor excision 66 TroVax ® 66 Medullary thyroid cancer 66 TACE 66 chemoresistant 66 adriamycin 66 seminoma 66 Accelerated Partial Breast Irradiation 66 needle aspiration 66 resistant hormone refractory 66 adenomyosis 66 histologic subtype 66 indolent lymphomas 66 progression TTP 66 antithrombotic therapy 66 autologous transplants 66 invasive candidiasis 66 ductal breast cancer 66 recanalization 66 antibiotic regimens 66 IV NSCLC 66 unresectable tumors 66 LHRH receptor positive 66 metastatic GIST 66 SLNB 66 colorectal carcinoma 66 TURBT 66 nodal metastasis 66 histopathologic examination 66 CMV disease 66 BCG refractory 66 mediastinitis 66 pamidronate 66 penetrating keratoplasty 66 pleurodesis 66 CYT# potent vascular disrupting 66 estramustine 66 renal biopsy 66 partial remissions 66 vaginal hysterectomy 66 esophagectomy 66 CHOP chemotherapy 66 HBeAg negative 66 5FU 66 5-fluorouracil/leucovorin 66 surgically resectable 66 fibrinolysis 66 perioperatively 66 taxane chemotherapy 66 autologous transplant 66 variceal hemorrhage 66 cerebral angiography 66 paroxysmal AF 66 Adjuvant therapy 66 chemotherapy cisplatin 66 FUSILEV enhances 66 varices 66 nephrectomies 66 palliative radiotherapy 66 malignant neoplasm 66 thymoma 66 bladder carcinoma 66 liposomal doxorubicin 66 renal transplantation 66 mucinous 66 surgical revascularization 66 recurrent glioblastoma 66 antiangiogenic therapy 66 biochemical recurrence 66 remission CR 66 chronic hemodialysis 66 T1c 66 prostate TURP 66 dysplastic lesions 66 TURP 66 cytoreductive nephrectomy 66 metastatic RCC 65 primary hyperparathyroidism 65 osteoporotic compression fractures 65 hormone refractory 65 allogeneic transplant 65 metastatic renal 65 prostate cancer CaP 65 transplantation HSCT 65 fibroma 65 pegylated liposomal doxorubicin 65 mutated K ras 65 thrombocytosis 65 wedge resection 65 Candida infection 65 oblimersen 65 transthoracic 65 myoma 65 peritoneal cancer 65 Hepatocellular Carcinoma HCC 65 hypervascular tumors 65 H. pylori eradication 65 allogeneic bone marrow 65 Stage IIB 65 immunomodulatory therapy 65 heavily pretreated patients 65 Bezielle 65 lymph node removal 65 oral Hycamtin 65 pelvic lymph node dissection 65 differentiated thyroid 65 gastroesophageal junction 65 budesonide foam 65 oncologic outcomes 65 perioperative complications 65 neoplasias 65 autologous transplantation 65 cranial irradiation 65 adenomatous polyps 65 basal cell carcinoma BCC 65 histologically confirmed 65 medically inoperable 65 antimicrobial prophylaxis 65 Chronic pancreatitis 65 retransplantation 65 Venous thromboembolism 65 anthracycline taxane 65 urethral stricture 65 pT3 65 interferon ribavirin 65 Kidney transplantation 65 multimodality therapy 65 relapsed ovarian cancer 65 urothelial cancer 65 photocoagulation 65 paracentesis 65 Combination therapy 65 interstitial brachytherapy 65 Cardiopulmonary bypass 65 radiofrequency ablation RFA 65 catheter angiography 65 ANCA associated 65 adverse cytogenetics 65 lung metastasis 65 cytogenetic response 65 thyroidectomy 65 adjuvant cisplatin 65 carcinoids 65 total abdominal hysterectomy 65 HSCT 65 femoral neck fracture 65 corticosteroid therapy 65 alkylating agent 65 therapeutic regimens 65 bronchogenic carcinoma 65 axillary lymph node dissection 65 #Gy 65 stage IIIB 65 occlusive disease 65 decompressive surgery 65 para aortic 65 Papillary 65 refractory Hodgkin 65 trastuzumab Herceptin ® 65 leukemia AML 65 metastatic kidney 65 chemo radiotherapy 65 invasive ductal 65 HoLEP 65 Sezary syndrome 65 gadolinium enhanced 65 ductal carcinomas 65 metaplasia 65 graft dysfunction 65 chorioamnionitis 65 haematologic 65 pulmonary dysfunction 65 axilla 65 Flu Cy 65 intracavitary 65 BEACOPP 65 gemcitabine carboplatin 65 prostate adenocarcinoma 65 mRCC 65 adenomatous 65 Gliadel Wafer 65 cystic lesions 65 intra arterial 65 nonoperative treatment 65 Glioblastoma Multiforme 65 pouchitis 65 sleeve lobectomy 65 VATS lobectomy 65 myocardial revascularization 65 distant metastases 65 androgen blockade 65 hepatocellular carcinomas 65 microsphere therapy 65 cervical carcinoma 65 repair TEVAR 65 Toxicities 65 HNSCC 65 polycythemia vera essential thrombocythemia 65 heavily pretreated 65 idiopathic myelofibrosis 65 sacrocolpopexy 64 androgen suppression therapy 64 transurethral 64 cytotoxic chemotherapy 64 segmentectomy 64 transarterial chemoembolization 64 valve implantation 64 radical prostatectomy RP 64 Aortic valve replacement 64 keratoplasty 64 Retreatment 64 refractory colorectal cancer 64 metastatic neuroendocrine tumors 64 Mitoxantrone 64 allogeneic stem cell 64 Hurthle cell 64 baseline LDH 64 carcinoma HCC 64 colorectal adenoma 64 submandibular gland 64 antireflux surgery 64 EGFR mutation positive 64 gemcitabine Gemzar 64 tuberous sclerosis TS 64 intraoperative complications 64 benign prostatic hyperplasia enlarged 64 invasive lobular carcinoma 64 noninvasive outpatient 64 metastatic lymph nodes 64 biliary strictures 64 immunosuppressive regimen 64 KRAS mutations occur 64 imipenem 64 perioperative mortality 64 orthotopic 64 colectomy 64 benign nodules 64 hydronephrosis 64 conventional angiography 64 nonproliferative 64 papillary thyroid carcinoma 64 imatinib Gleevec 64 Anthracycline 64 esophageal gastric 64 Hormonal therapy 64 lymphocytosis 64 intradermal injection 64 thalidomide Thalomid 64 stratifying patients 64 histologically proven 64 percutaneous intervention 64 choriocarcinoma 64 endometrial hyperplasia 64 intravenous cyclophosphamide 64 secondary amenorrhea 64 neurofibromas 64 oral anticoagulation 64 allograft rejection 64 axillary node dissection 64 RALP 64 pulmonary metastasis 64 intraperitoneal 64 appendiceal 64 metastatic renal cell carcinoma 64 GnRH agonist 64 colonoscopic 64 postsurgical 64 intralesional 64 fluorouracil 64 micafungin 64 carcinomatosis 64 paclitaxel Taxol ® 64 pituitary adenomas 64 LNG IUS 64 lymphadenopathy 64 mycosis fungoides 64 posttransplant 64 basal cell cancers 64 immunosuppressive regimens 64 urothelial bladder cancer 64 sorafenib Nexavar 64 refractory AML 64 renal cysts 64 Breast conserving 64 metastatic colorectal 64 Gleevec resistant 64 beam radiotherapy 64 small lymphocytic lymphoma 64 Lung transplantation 64 relapsing remitting MS RRMS 64 remission induction 64 monophasic 64 pancreaticoduodenectomy 64 paragangliomas 64 cisplatin resistant 64 HER2 positive cancers 64 gemcitabine chemotherapy 64 HDR brachytherapy 64 HBeAg seroconversion 64 ribavirin RBV 64 neovascularisation 64 virological response 64 osteochondromas 64 hematopoietic cancers 64 invasive carcinoma 64 mitomycin C 64 ara C 64 EGFR TKI 64 MCyR 64 Radio Frequency Ablation 64 variceal 64 ischemic mitral regurgitation 64 epithelial ovarian cancer 64 seminomas 64 transabdominal 64 FOLFOX6 64 pacemaker implantation 64 pancreatic carcinoma 64 Sentinel node biopsy 64 pancreatic lung 64 temozolomide Temodar 64 complete remissions 64 Circulating tumor cells 64 sclerosing 64 unresectable HCC 64 nonoperative 64 myocardial reperfusion 64 HER2 expression 64 acute GvHD 64 antiangiogenic agents 64 metastatic lung cancer 64 nonischemic 64 anthracycline containing 64 LHRH agonists 64 invasive carcinomas 64 lumbar disc herniation 64 artery embolization 64 nonsmall cell lung cancer 64 Intravenous CP 64 extracranial 64 intraventricular 64 refractory ovarian cancer 64 carcinoid tumors 64 stage IIIb IV 64 precancerous condition 64 HER2 overexpression 64 contralateral breast 64 pretransplant 64 docetaxel Taxotere ® 64 pancreatectomy 64 Basal cell 64 idarubicin 64 PSADT 64 repigmentation 64 BrachySil TM 64 metastatic ovarian cancer 64 ALA PDT 64 patients undergoing CABG 64 esophageal candidiasis 64 Acute myeloid leukemia 64 laser photocoagulation 64 gemcitabine cisplatin 64 thymic carcinoma 64 hepatic metastasis 64 ovarian stimulation 64 antiestrogen therapy 64 antithymocyte globulin 63 nondiabetic patients 63 metastatic pancreatic 63 tamoxifen therapy 63 Heavy menstrual bleeding 63 renal carcinoma 63 paclitaxel Taxol R 63 adjuvant hormonal therapy 63 thromboembolic disease 63 ASCT 63 dasatinib Sprycel 63 resection arthroplasty 63 antiandrogen 63 PAOD 63 bypass grafting 63 chlorambucil 63 antegrade 63 lobectomy 63 neuroendocrine cancers 63 paclitaxel poliglumex 63 corifollitropin alfa 63 Ductal carcinoma 63 Metastatic colorectal cancer 63 allogeneic hematopoietic cell 63 leiomyosarcoma 63 RAS mutations 63 percutaneous nephrolithotomy 63 urethral strictures 63 ischemic lesions 63 pediatric acute lymphoblastic 63 recurrent NSCLC 63 rFVIIa 63 Prognostic factors 63 corticosteroid dexamethasone 63 induce remission 63 colorectal adenocarcinoma 63 FIRMAGON 63 microwave hyperthermia 63 pancreatic resection 63 OPCAB 63 F FDG PET 63 percutaneous vertebroplasty 63 Fludarabine 63 capecitabine Xeloda 63 serous ovarian cancer 63 balloon valvuloplasty 63 taxane chemotherapy administered 63 intratumoral 63 N. gonorrhoeae 63 Pemetrexed 63 K ras mutations 63 intra abdominal infections 63 receptor tyrosine kinase inhibitor 63 thrombotic complications 63 histological subtype 63 tumor histology 63 chemotherapy radiotherapy 63 complement inhibitor eculizumab 63 liposomal amphotericin B 63 oxaliplatin Eloxatin 63 chemotherapeutic regimen 63 PCNSL 63 pyrimethamine 63 Nonsurgical 63 superficial bladder cancer 63 Mitral valve repair 63 chemotherapy docetaxel 63 invasive fungal infection 63 completely resected 63 TKI therapy 63 gastric carcinoma 63 stage IIIB IV 63 lenalidomide Revlimid R 63 Coronary artery bypass 63 rFSH 63 pathologic examination 63 Hodgkin lymphoma HL 63 GIST tumors 63 Duodenal 63 papillary carcinoma 63 omega interferon 63 thalidomide dexamethasone 63 stereotactic radiotherapy 63 pancreatic NET 63 response CCyR 63 underwent radical cystectomy 63 pelvic radiotherapy 63 carcinoid tumor 63 GnRH agonists 63 pleural mesothelioma 63 intermittent hemodialysis 63 intrahepatic 63 hypofractionated 63 anthracyclines taxanes 63 TRUS biopsy 63 aortic root replacement 63 dose melphalan 63 cisplatin gemcitabine 63 CRp 63 laparoscopic nephrectomy 63 caspofungin 63 antitumor effect 63 advanced adenoma 63 hamartomas 63 busulfan 63 gefitinib Iressa 63 MGd 63 refractory prostate cancer 63 pleomorphic 63 coronary stenting 63 median sternotomy 63 hormonal therapies 63 thyroid nodules 63 metastatic renal cell 63 percutaneous biopsy 63 preoperative staging 63 intravesical 63 hypertrophic scars 63 hepatic arterial 63 platinum refractory 63 plasminogen activators 63 NATRECOR ® 63 skin sparing mastectomy 63 CLL SLL 63 Carotid stenting 63 cranial radiation 63 cervical intraepithelial neoplasia 63 relapsed AML 63 antibiotic prophylaxis 63 Ribavirin causes 63 opioid analgesia 63 intracranial hemorrhage ICH 63 bleomycin 63 calcineurin inhibitor 63 premalignant lesions 63 steroid refractory 63 thrombocytopenic 63 BRCA deficient 63 anaplastic thyroid carcinoma 63 donor nephrectomy 63 thyroid carcinoma 63 mCRPC 63 receiving highly emetogenic 63 hemorrhagic complications 63 mediastinal 63 response pCR 63 benign prostatic hypertrophy BPH 63 Brain metastases 63 doxorubicin cyclophosphamide 63 ductal cancer 63 tumor recurrence 63 lobular carcinoma 63 Tumor Response 63 squamous histology 63 durable remissions 63 Fontan procedure 63 urine cytology 63 malignant neoplasms 63 Postoperatively 63 decompensated cirrhosis 63 post thrombotic syndrome 63 cutaneous squamous cell carcinoma 63 MYLOTARG 63 Pegylated Interferon 63 ER CHOP 63 intravenous vancomycin 63 OnDose TM 63 sonographically guided 63 postoperative complication 63 advanced hepatocellular carcinoma 63 precancerous cervical lesions 63 deep venous thromboses 63 prostate cancer CRPC 63 cerebral vasospasm 63 Carcinoma 63 TTF Therapy 63 malignant pleural mesothelioma MPM 63 paclitaxel cisplatin 63 mastectomy chemotherapy 63 imatinib therapy 63 infusional 63 urolithiasis 63 stem cell engraftment 63 anagrelide 63 Lymph node 63 gastroduodenal 63 rebleeding 63 FOLFIRINOX 63 mTOR inhibitors 63 lipomas 63 β blockers 63 severe neutropenia 63 fibrin deposition 63 wound dehiscence 63 nadolol 63 paraganglioma 63 VNP#M 63 irinotecan chemotherapy 63 RF ablation 63 recurrent malignant glioma 63 less invasive laparoscopic 63 lymph node enlargement 63 epirubicin 63 docetaxel Taxotere 63 trans retinoic acid ATRA 63 alfa 2a 63 detectable HCV RNA 63 tenecteplase 63 axillary lymph node 63 hormone receptor negative 63 radiolabeled antibodies 63 Irinotecan 63 Coronary Artery Bypass Graft 63 recombinant FSH 63 uterine fibroid 62 Squamous 62 hemorrhagic cystitis 62 endobronchial 62 immune dysregulation 62 Hormone Refractory Prostate Cancer 62 visceral metastases 62 immunocompetent 62 bolus dose 62 metastatic CRC 62 Cryoablation 62 radiation chemoradiation 62 cinacalcet 62 resected 62 splenic 62 KRAS mutant tumors 62 trans retinoic acid 62 pegylated interferon alfa 62 Gleevec imatinib 62 haematopoietic 62 tumors GIST 62 prospective multicenter study 62 dexamethasone Decadron 62 immunosuppressive medications 62 taxane therapy 62 FDG PET imaging 62 Paraplatin ® 62 surgical resection cavity 62 Oral corticosteroids 62 hematologic toxicity 62 pyrazinamide 62 chronic thromboembolic pulmonary 62 lung carcinomas 62 hyperacute 62 methotrexate therapy 62 nonmetastatic prostate cancer 62 cytotoxic effects 62 submucosal 62 gastrointestinal stromal tumors GIST 62 % CI #.#-#.# [003] 62 anti angiogenic therapy 62 cutaneous melanoma 62 atypical ductal hyperplasia 62 posttraumatic arthritis 62 Xelox 62 percutaneous cryoablation 62 EGFRIs 62 CIN3 62 CTAP# Capsules 62 Alocrest 62 metastatic liver 62 octreotide LAR 62 portal vein thrombosis 62 cytotoxic therapies 62 grade cervical dysplasia 62 sentinel node biopsy 62 reinterventions 62 conformal radiotherapy 62 malignant growths 62 postoperative infection 62 ximelagatran 62 pathologic diagnosis 62 FluCAM 62 genotypic resistance 62 CIMZIA ™ 62 #F FDG PET 62 radiographic findings 62 neoplastic lesions 62 postoperative mortality 62 lumbar disk herniation 62 breast abscesses 62 breast carcinomas 62 mesotheliomas 62 pharmacologic intervention 62 bladder prostate 62 ureteroscopy 62 refractory acute myeloid 62 Catheter ablation 62 lobular carcinomas 62 corneal graft 62 mycophenolate mofetil MMF 62 spontaneous regression 62 epithelial ovarian 62 surgical decompression 62 fallopian tube cancers 62 flutamide 62 transplant ASCT 62 atelectasis 62 Anaplastic 62 HER2 amplified 62 hyperalgesia 62 tumor regressions 62 UPPP 62 MRgFUS 62 renal parenchyma 62 resection 62 EGFR tyrosine kinase inhibitors 62 myelodysplastic myeloproliferative diseases 62 systemic anaplastic large 62 recurrent GBM 62 decortication 62 standard chemotherapy regimens 62 ICD implantation 62 monoclonal gammopathy 62 microdebrider 62 mediastinal lymph nodes 62 Dacogen decitabine 62 unresectable stage 62 FDG uptake 62 interferon beta therapy 62 Hypotension 62 Resection 62 Wilms tumors 62 Fludara ® 62 intravenous bisphosphonates 62 radiotherapy chemotherapy 62 denervation 62 nonsurgical treatment 62 postoperative atrial fibrillation 62 HER2 positivity 62 IDH mutations 62 transgene expression 62 PSMA ADC 62 pericardial effusion 62 prognostic indicator 62 recurrent VTE 62 cyclophosphamide chemotherapy 62 transfusion syndrome 62 neoadjuvant radiation 62 neoadjuvant setting 62 Renal Cell Carcinoma RCC 62 myelofibrosis polycythemia vera 62 ADPKD 62 papillomas 62 bowel resection 62 NNRTI resistance 62 CABG coronary artery 62 hamartoma 62 taxane refractory 62 previously untreated follicular 62 carcinoid 62 gastric cardia 62 dose cohort 62 Acute Myeloid Leukaemia AML 62 pemphigus vulgaris 62 recurrent prostate cancer 62 duplex ultrasonography 62 pheochromocytoma 62 neointimal hyperplasia 62 clodronate 62 LHRH antagonists 62 imiquimod cream 62 radical hysterectomy 62 polyp recurrence 62 transrectal 62 BEXXAR Therapeutic Regimen 62 Vidaza azacitidine 62 riociguat 62 demonstrated antitumor activity 62 biliary obstruction 62 ertapenem 62 malignant lymphoma 62 tumoral 62 haematological cancers 62 SSc 62 Neoadjuvant chemotherapy 62 pathologic fractures 62 hormone receptor status 62 postoperative AF 62 ablation procedures 62 fluorouracil leucovorin 62 deferoxamine 62 pancreatic colon 62 VTE prophylaxis 62 ano genital warts 62 neoplasia 62 nonmyeloablative 62 unresectable 62 Histologically 62 epirubicin cyclophosphamide 62 Postoperative complications 62 metachronous 62 core needle biopsy 62 ureteric 62 ipsilateral breast 62 antiemetics 62 steatohepatitis 62 ASCUS 62 evaluable subjects 62 Acute renal failure 62 micrometastases 62 atypical hyperplasia 62 direct thrombin inhibitors 62 Waldenstrom macroglobulinemia 62 5 fluorouracil leucovorin 62 Alessandro Riva 62 node metastases 62 nonmelanoma skin cancers 62 gemcitabine Gemzar ® 62 solar keratoses 62 Inhaled nitric oxide 62 Leucovorin 62 mycophenolate mofetil 62 AV fistulas 62 fine needle aspiration 62 saphenous vein grafts 62 nodal dissection 62 MDS AML 62 aerosolized KL4 surfactant 62 incisional 62 Thal Dex 62 preoperative diagnosis 62 cyclophosphamide methotrexate 62 tiuxetan 62 Fludara 62 Chronic lymphocytic leukemia 62 excisional biopsy 62 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 62 axillary nodes 62 transfemoral approach 62 ductal adenocarcinoma 62 achieved CCyR 62 Radioimmunotherapy 62 endovascular aneurysm repair 62 parathyroid carcinoma 62 bronchoalveolar lavage 62 elevated LDH 62 LHRH agonist